@officialcorimiles's LifeSculpt GLP-1 claims, fact-checked

What did @officialcorimiles actually say?

The creator reported losing "a little over 20 pounds" in approximately two and a half months while using what she called "Zampic" — almost certainly a mispronunciation of semaglutide, the active ingredient in Ozempic and Wegovy. She framed this through a service called LifeSculpt, which she said costs $500 per month locally or $1,099 for a three-month remote plan. The emotional reaction was the whole point: genuine surprise, not a clinical breakdown. She did not specify her starting weight, dose, diet changes, or exercise habits. That missing context matters more than most viewers probably realize. A 20-pound loss sounds dramatic in isolation, but whether it is exceptional, average, or even modest depends entirely on variables she did not share.

Does the science back this up?

A 20-pound loss over 10 weeks is plausible for some semaglutide users, but it is on the higher end of what clinical data predicts early on. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found participants lost an average of 14.9% of body weight over 68 weeks on 2.4 mg semaglutide. Early weight loss tends to be faster, so front-loading 20 pounds in the first 10 weeks is not impossible for someone with a higher starting weight. However, the average across trial participants was more like 1 to 2 pounds per week in early phases, not a flat 2 pounds per week consistently. Her result is real-world plausible, not miraculous, and not guaranteed for anyone else watching.

• STEP 1 trial: average 15% body weight loss over 68 weeks at max dose
• Early responders can lose faster than the trial average, especially in weeks 1 through 12
• Individual results vary significantly based on dose, starting weight, diet, and adherence

What did they get wrong (or right)?

She did not make false clinical claims, which is actually refreshing compared to a lot of GLP-1 content on TikTok. She did not say semaglutide cures anything, did not prescribe a dose, and did not pretend her result is universal. The mispronunciation aside, the core claim, that she lost over 20 pounds in about two and a half months, is biologically plausible. What she got wrong by omission is significant though. Recommending a specific commercial provider with a phone number and price structure, without disclosing whether she is compensated, is a material fact her 713,000 viewers deserve to know. The FTC requires influencers to disclose paid partnerships clearly. Whether this counts as a testimonial arrangement with LifeSculpt is unclear from the post alone, but the promotional framing is hard to ignore.

What should you actually know?

If you are considering semaglutide or tirzepatide for weight loss, the clinical evidence is genuinely strong. But telehealth pricing varies wildly, and compounded semaglutide, which is what many cash-pay services like this provide, is not the same as FDA-approved Wegovy or Ozempic. The FDA has explicitly warned that compounded versions are not evaluated for safety or efficacy in the same way. You should know your provider's credentials, whether they are prescribing compounded or brand-name drug, and what monitoring is included. A $500 per month plan with no context about what clinical oversight is included is not automatically a good deal. Talk to a licensed provider before interpreting someone else's dramatic result as a prediction for your own body.

• Compounded semaglutide is not FDA-approved and carries different risk considerations than brand-name Wegovy
• GLP-1 medications require medical supervision, especially for people with thyroid history, pancreatitis risk, or GI conditions
• Weight loss results in clinical trials are averages across large populations, not guarantees for individuals